BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. ✅
Go to Publication ✅
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 14 Issue Pages: 386 Pub: 2014 Oct 10 Epub: 2014 Oct 10 Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Zhao T , Qu H , Huang J , Wu Y , Gu R , |
|
|
The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. ✅
Go to Publication ✅
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 14 Issue Pages: 386 Pub: 2014 Oct 10 Epub: 2014 Oct 10 Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Zhao T , Qu H , Huang J , Wu Y , Gu R , |
|
|
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅
Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322 Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO , |
|
|
Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 9 Issue 1 Pages: 61-70 Pub: 2018 Jan 29 Epub: 2017 Oct 25 Authors Lau AS , Yanagisawa N , Hor YY , Lew LC , Ong JS , Chuah LO , Lee YY , Choi SB , Rashid F , Wahid N , Sugahara H , Xiao JZ , Liong MT , |
|
|
Lactobacillus rhamnosus GG Ameliorated Long-Term Exposure to TiO(2) Nanoparticles Induced Microbiota-Mediated Liver and Colon Inflammation and Fructose-Caused Metabolic Abnormality in Metabolism Syndrome Mice. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 34 Pages: 9788-9799 Pub: 2021 Sep 1 Epub: 2021 Aug 12 Authors Zhao Y , Liu S , Tang Y , You T , Xu H , |
|
|
Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 10 Issue 7 Pages: Pub: 2022 Jul 21 Epub: 2022 Jul 21 Authors Gupta H , Kim SH , Kim SK , Han SH , Kwon HC , Suk KT , |
|
|
Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 10 Issue 7 Pages: Pub: 2022 Jul 21 Epub: 2022 Jul 21 Authors Gupta H , Kim SH , Kim SK , Han SH , Kwon HC , Suk KT , |
|
|
Lacticaseibacillus rhamnosus HN001 alters the microbiota composition in the cecum but not the feces in a piglet model. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1002369 Pub: 2022 Epub: 2022 Oct 28 Authors Young W , Maclean P , Dunstan K , Ryan L , Peters J , Armstrong K , Anderson R , Dewhurst H , van Gendt M , Dilger RN , Dekker J , Haggarty N , Roy N , |
|
|
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 15460 Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Aktas B , Aslim B , Ozdemir DA , |
|
|
Fermented Milk Containing Lacticaseibacillus rhamnosus SNU50430 Modulates Immune Responses and Gut Microbiota in Antibiotic-Treated Mice. ✅
Go to Publication ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 34 Issue 6 Pages: 1299-1306 Pub: 2024 Jun 28 Epub: 2024 Apr 30 Authors Yoon S , Park S , Jung SE , Lee C , Kim WK , Choi ID , Ko G , |
|
|
Lacticaseibacillus rhamnosus Probio-M9-Driven Mouse Mammary Tumor-Inhibitory Effect Is Accompanied by Modulation of Host Gut Microbiota, Immunity, and Serum Metabolome. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 1 Pages: Pub: 2022 Dec 20 Epub: 2022 Dec 20 Authors Zhang W , Zhang Y , Li Y , Ma D , Zhang H , Kwok LY , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus Probio-M9 alleviates OVA-sensitized food allergy through modulating gut microbiota and its metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 24 Pages: 10784-10795 Pub: 2023 Dec 11 Epub: 2023 Dec 11 Authors Shi J , Dong P , Liu C , Xu Y , Zheng M , Cheng L , Wang J , Raghavan V , |
|
|
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. ✅
Journal of biological regulators and homeostatic agents (J Biol Regul Homeost Agents ) Vol: 28 Issue 4 Pages: 743-52 Pub: 2014 Oct-Dec Epub: Authors Orsi CF , Sabia C , Ardizzoni A , Colombari B , Neglia RG , Peppoloni S , Morace G , Blasi E , |
|
|
Anticandidal and Antibiofilm Effect of Synbiotics including Probiotics and Inulin-Type Fructans. ✅
Go to Publication ✅
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 11 Issue 8 Pages: Pub: 2022 Aug 21 Epub: 2022 Aug 21 Authors García-Gamboa R , Domínguez-Simi M , Gradilla-Hernández MS , Bravo J , Moya A , Ruiz-Álvarez B , González-Avila M , |
|
|
Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity. ✅
Go to Publication ✅
Nature communications (Nat Commun ) Vol: 13 Issue 1 Pages: 3192 Pub: 2022 Jun 9 Epub: 2022 Jun 9 Authors Alonso-Roman R , Last A , Mirhakkak MH , Sprague JL , Möller L , Großmann P , Graf K , Gratz R , Mogavero S , Vylkova S , Panagiotou G , Schäuble S , Hube B , Gresnigt MS , |
|
|
Lacticaseibacillus rhamnosus BELR47 Mitigates Inflammatory Response in a Gardnerella vaginalis-Induced Bacterial Vaginosis Mouse Model via Gut Microbiome Modulation. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2025 Oct 27 Epub: 2025 Oct 27 Authors Bae HJ , Lee DH , Choi HS , Lim HJ , Chung EC , Oh NS , |
|
|
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 222 Issue Pt 2 Pages: 117757 Pub: 2025 Dec Epub: 2025 Oct 31 Authors Vaccalluzzo A , Celano G , Calabrese FM , Pino A , Caggia C , De Angelis M , Randazzo CL , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
